Eagle Global Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $577K | Hold |
1,640
| – | – | 0.02% | 191 |
|
|
2025
Q4 | $537K | Sell |
1,640
-30
| -2% | -$9.52K | 0.02% | 206 |
|
|
2025
Q3 | $471K | Hold |
1,670
| – | – | 0.02% | 210 |
|
|
2025
Q2 | $466K | Hold |
1,670
| – | – | 0.02% | 202 |
|
|
2025
Q1 | $520K | Hold |
1,670
| – | – | 0.02% | 194 |
|
|
2024
Q4 | $435K | Sell |
1,670
-50
| -3% | -$14.8K | 0.02% | 207 |
|
|
2024
Q3 | $554K | Hold |
1,720
| – | – | 0.03% | 170 |
|
|
2024
Q2 | $537K | Sell |
1,720
-1,000
| -37% | -$294K | 0.03% | 173 |
|
|
2024
Q1 | $773K | Hold |
2,720
| – | – | 0.04% | 153 |
|
|
2023
Q4 | $783K | Hold |
2,720
| – | – | 0.05% | 152 |
|
|
2023
Q3 | $731K | Hold |
2,720
| – | – | 0.05% | 152 |
|
|
2023
Q2 | $604K | Hold |
2,720
| – | – | 0.04% | 160 |
|
|
2023
Q1 | $658K | Hold |
2,720
| – | – | 0.04% | 154 |
|
|
2022
Q4 | $714K | Buy |
+2,720
| New | +$729K | 0.05% | 150 |
|
|
2022
Q3 | – | Sell |
-870
| Closed | -$212K | – | 217 |
|
|
2022
Q2 | $212K | Hold |
870
| – | – | 0.02% | 205 |
|
|
2022
Q1 | $210K | Buy |
+870
| New | +$200K | 0.01% | 217 |
|
|
2021
Q4 | – | Sell |
-50,535
| Closed | -$10.7M | – | 263 |
|
|
2021
Q3 | $10.7M | Sell |
50,535
-704
| -1% | -$162K | 0.71% | 43 |
|
|
2021
Q2 | $12.5M | Buy |
51,239
+156
| +0.3% | +$38.4K | 0.81% | 36 |
|
|
2021
Q1 | $12.7M | Sell |
51,083
-425
| -0.8% | -$101K | 0.94% | 30 |
|
|
2020
Q4 | $11.8M | Sell |
51,508
-1,735
| -3% | -$400K | 0.93% | 35 |
|
|
2020
Q3 | $13.5M | Sell |
53,243
-1,519
| -3% | -$376K | 1.22% | 27 |
|
|
2020
Q2 | $12.9M | Sell |
54,762
-384
| -0.7% | -$87.6K | 1.17% | 26 |
|
|
2020
Q1 | $11.2M | Buy |
55,146
+987
| +2% | +$216K | 1.13% | 26 |
|
|
2019
Q4 | $13.1M | Sell |
54,159
-1,305
| -2% | -$288K | 0.66% | 40 |
|
|
2019
Q3 | $10.7M | Buy |
55,464
+871
| +2% | +$167K | 0.46% | 50 |
|
|
2019
Q2 | $10.1M | Sell |
54,593
-10,160
| -16% | -$1.82M | 0.4% | 57 |
|
|
2019
Q1 | $12.3M | Sell |
64,753
-304
| -0.5% | -$58.1K | 0.48% | 45 |
|
|
2018
Q4 | $12.7M | Buy |
65,057
+34,201
| +111% | +$6.67M | 0.55% | 40 |
|
|
2018
Q3 | $6.4M | Buy |
30,856
+1,290
| +4% | +$254K | 0.2% | 83 |
|
|
2018
Q2 | $5.46M | Buy |
29,566
+371
| +1% | +$65.6K | 0.17% | 90 |
|
|
2018
Q1 | $4.98M | Buy |
29,195
+4,604
| +19% | +$845K | 0.17% | 99 |
|
|
2017
Q4 | $4.28M | Buy |
24,591
+880
| +4% | +$156K | 0.13% | 112 |
|
|
2017
Q3 | $4.42M | Buy |
23,711
+840
| +4% | +$149K | 0.13% | 111 |
|
|
2017
Q2 | $3.94M | Buy |
22,871
+4,567
| +25% | +$743K | 0.11% | 119 |
|
|
2017
Q1 | $3M | Buy |
18,304
+3,514
| +24% | +$584K | 0.08% | 127 |
|
|
2016
Q4 | $2.16M | Sell |
14,790
-27,579
| -65% | -$4.15M | 0.06% | 132 |
|
|
2016
Q3 | $7.07M | Sell |
42,369
-329
| -0.8% | -$55.6K | 0.2% | 85 |
|
|
2016
Q2 | $6.5M | Buy |
42,698
+46
| +0.1% | +$7.15K | 0.19% | 91 |
|
|
2016
Q1 | $6.39M | Sell |
42,652
-45
| -0.1% | -$6.69K | 0.23% | 95 |
|
|
2015
Q4 | $6.93M | Sell |
42,697
-5,154
| -11% | -$810K | 0.24% | 92 |
|
|
2015
Q3 | $6.62M | Buy |
47,851
+26,695
| +126% | +$4.21M | 0.22% | 94 |
|
|
2015
Q2 | $3.25M | Sell |
21,156
-544
| -3% | -$87.1K | 0.08% | 137 |
|
|
2015
Q1 | $3.47M | Buy |
21,700
+320
| +1% | +$50.4K | 0.09% | 135 |
|
|
2014
Q4 | $3.41M | Buy |
+21,380
| New | +$3.33M | 0.09% | 137 |
|
Other funds holding AMGN
VCM
VPM
Eagle Global Advisors's AMGN Position: Q1 2026 in Review
Eagle Global Advisors held its Amgen (AMGN) position steady in Q1 2026 at 1,640 shares worth $577K. The position accounts for 0.02% of the portfolio, ranked #191.
Eagle Global Advisors first reported a position in AMGN in Q4 2014 and has held it in 44 quarters since. The position peaked at $13.5M in Q3 2020. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Eagle Global Advisors held 1,640 shares of Amgen worth $577K as of Q1 2026.
- Eagle Global Advisors left its Amgen share count unchanged in Q1 2026.
- Amgen made up 0.02% of Eagle Global Advisors's portfolio in Q1 2026, its #191 holding.
- Eagle Global Advisors first reported a position in Amgen in Q4 2014 and has held it in 44 quarters since.
- Eagle Global Advisors's Amgen position peaked at $13.5M in Q3 2020.
- 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Eagle Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.